Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

This randomized, multicenter trial showed no differences in 28-day mortality in patients with shock who received either norepinephrine or dopamine, but did reveal a higher incidence of arrhythmia in the dopamine-treated group.

Which Vasopressor Is Best in Patients with Shock?